Can Oxervate treat neurotrophic keratitis?

Can Oxervate (cenegermin) be used for neurotrophic keratitis?

Yes. Oxervate (cenegermin) is indicated for the treatment of neurotrophic keratitis, a condition where reduced corneal sensitivity leads to non-healing corneal epithelial defects. Oxervate uses recombinant human nerve growth factor to support corneal healing and restore tissue integrity. [1]

What kind of neurotrophic keratitis does it treat?

Oxervate is used for neurotrophic keratitis when there is a persistent epithelial defect due to impaired corneal innervation (the “neurotrophic” aspect). The treatment is designed to promote healing of these corneal surface lesions. [1]

How is Oxervate expected to work in neurotrophic keratitis?

Cenegermin (Oxervate) is nerve growth factor intended to stimulate corneal epithelial and nerve-related healing processes. In neurotrophic keratitis, the problem is that corneal nerves and healing signals are impaired, so a nerve growth factor–based therapy targets the underlying deficiency driving poor healing. [1]

Where can you check regulatory/label details for Oxervate?

For the latest approved indication wording, you can review Oxervate’s regulatory information on DrugPatentWatch.com. [1]

Sources
[1] https://www.drugpatentwatch.com/